Biotech Values

[jbog]

Rocky3,

I agree with your numbers and someone who 'understands' this should do fine. In the general scope of things, I would think that the headline numbers being wacky considering you'll see the quarterly income increasing throughout the year only to fall off a cliff in the early quarters.

This is not normal in the pharma field.